Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This study investigates the safety, pharmacokinetic (PK) profile and efficacy of a single
injection of COVI-AMG in outpatient adults with mild COVID-19 symptoms.